Donna Parr
Director/Board Member chez CONSTELLATION SOFTWARE INC.
Fortune : 222 612 $ au 31/03/2024
Profil
Donna Parr is currently an Independent Director at Constellation Software, Inc., a Director at ViOptix, Inc., Twinstrand Therapeutics, Inc., CellAegis Devices, Inc., and Centurion Asset Management, Inc. She is also a Non-Executive Director at Topicus.com, Inc. and Topicus.com BV.
Additionally, she is the Managing Partner at Cross-Border Impact Ventures.
Previously, she was a Director at Constellation Software, Inc. from 1995 to 2003, a Director at Adnavance Technologies, Inc., a Senior Vice President at MedTech Partners, Inc., and a Senior Vice President at Medical Discovery Management Corp.
from 2006 to 2009.
Ms. Parr holds an MBA from York University and a graduate degree from the University of Toronto.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 27/03/2023 | 46 ( 0,00% ) | 125 787 $ | 31/03/2024 | |
TOPICUS.COM, INC.
0,00% | 27/03/2023 | 1 051 ( 0,00% ) | 93 115 $ | 31/03/2024 |
LUMINE GROUP INC.
0,00% | 27/03/2023 | 138 ( 0,00% ) | 3 709 $ | 31/03/2024 |
Postes actifs de Donna Parr
| Sociétés | Poste | Début |
|---|---|---|
| CONSTELLATION SOFTWARE INC. | Director/Board Member | 02/06/2020 |
| TOPICUS.COM INC. | Director/Board Member | 01/01/2020 |
Twinstrand Therapeutics, Inc.
 Twinstrand Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Twinstrand Therapeutics Inc. manufactures and distributes biological drugs. It focuses on discovering, developing and commercializing of therapeutics for the treatment of cancer, hepatitis A, cytomegalovirus, malaria, schistosomiasis, and fungal diseases. The company was founded in 1995 and is located in North Vancouver, Canada. | Director/Board Member | - |
CellAegis Devices, Inc.
 CellAegis Devices, Inc. Electronic Equipment/InstrumentsElectronic Technology CellAegis Devices, Inc. develops device for the treatment of cardiac patients. . It offers autoRIC Device, an automated noninvasive device that provides point of care delivery of remote ischemic conditioning. The company was founded by John Berton, Andrew N. Redington and Christopher Caldarone and is headquartered in Toronto, Canada. | Director/Board Member | - |
Crimson Capital, Inc.
 Crimson Capital, Inc. Financial ConglomeratesFinance Crimson Capital, Inc. provides investment services. The joint venture company is based in Albany, NY. The company was founded by Roland Eschle. Linda Boland Abraham has been the CEO of the company since 2014. | President | 01/01/2009 |
ViOptix, Inc.
 ViOptix, Inc. Medical SpecialtiesHealth Technology ViOptix, Inc. develops a tissue oximetry technology for the measurement of local tissue oxygen saturation. It offers T.Ox Tissue Oximeter, a lightweight and portable A/C power-operated unit. The was founded in 2009 and is headquartered in Fremont, CA. | Director/Board Member | - |
| Centurion Asset Management, Inc. | Director/Board Member | - |
Topicus.com BV
 Topicus.com BV Packaged SoftwareTechnology Services Part of Topicus.com, Inc., Topicus.com BV provides vertical market software and platforms. The private company is based in Deventer, Netherlands. Robin van Poelje has been the CEO of the Dutch company since 2021. | Director/Board Member | 01/01/2020 |
Cross-Border Impact Ventures
 Cross-Border Impact Ventures Investment ManagersFinance Cross-Border Impact Ventures (Cross-Border Impact Ventures) is a venture capital firm founded in 2019 by Megan Dover. The firm is headquartered in Toronto, Canada. | Private Equity Investor | 01/05/2019 |
Anciens postes connus de Donna Parr
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░ ░░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Formation de Donna Parr
| York University | Masters Business Admin |
| University of Toronto | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CONSTELLATION SOFTWARE INC. | Technology Services |
| Entreprise privées | 11 |
|---|---|
ViOptix, Inc.
ViOptix, Inc. Medical SpecialtiesHealth Technology ViOptix, Inc. develops a tissue oximetry technology for the measurement of local tissue oxygen saturation. It offers T.Ox Tissue Oximeter, a lightweight and portable A/C power-operated unit. The was founded in 2009 and is headquartered in Fremont, CA. | Health Technology |
Adnavance Technologies, Inc.
 Adnavance Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Adnavance is a molecular diagnostic company focused on development of DNA-based tests using the Company's patented metalized DNA (M-DNA) platform. The Company is headquartered in Vancouver, British Columbia and also maintains a DNA development laboratory in San Diego, CA. M-DNA is based on the conducting properties of hybridized DNA. Under strict reaction conditions, certain metal ions can enter the central core of hybridized DNA and displace the hydrogen bonds forming the equivalent of a metal wire in the center of the DNA and making the DNA highly conductive. The Company uses a microarray of 10-micron electrodes to detect the M-DNA and the inherent ultra-sensitivity arises from the differential change in conductivity between hybridized DNA and metalized DNA. This change in conductivity is so large that it obviates the need for target amplification used in current molecular-based tests. Adnavance scientists were the first to discover the M-DNA phenomenon, and the Company believes its technology platform will open new molecular testing markets. | Commercial Services |
MedTech Partners, Inc.
 MedTech Partners, Inc. Investment ManagersFinance MedTech Partners, Inc. provides investment services. The firm offers investment services to develop and commercialize early-stage biomedical innovations. The company is headquartered in Nepean, Ontario. | Finance |
Twinstrand Therapeutics, Inc.
Twinstrand Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Twinstrand Therapeutics Inc. manufactures and distributes biological drugs. It focuses on discovering, developing and commercializing of therapeutics for the treatment of cancer, hepatitis A, cytomegalovirus, malaria, schistosomiasis, and fungal diseases. The company was founded in 1995 and is located in North Vancouver, Canada. | Health Technology |
Medical Discovery Management Corp.
 Medical Discovery Management Corp. Investment ManagersFinance Medical Discovery Management Corp. (MDMC) is a venture capital fund manager located in Toronto. They are a subsidiary of JovFunds Management, Inc. Their ultimate parent is Jovian Capital Corp. (Toronto: JOV.TO) | Finance |
Crimson Capital, Inc.
Crimson Capital, Inc. Financial ConglomeratesFinance Crimson Capital, Inc. provides investment services. The joint venture company is based in Albany, NY. The company was founded by Roland Eschle. Linda Boland Abraham has been the CEO of the company since 2014. | Finance |
CellAegis Devices, Inc.
CellAegis Devices, Inc. Electronic Equipment/InstrumentsElectronic Technology CellAegis Devices, Inc. develops device for the treatment of cardiac patients. . It offers autoRIC Device, an automated noninvasive device that provides point of care delivery of remote ischemic conditioning. The company was founded by John Berton, Andrew N. Redington and Christopher Caldarone and is headquartered in Toronto, Canada. | Electronic Technology |
| Centurion Asset Management, Inc. | Miscellaneous |
| Topicus.com, Inc. | |
Topicus.com BV
Topicus.com BV Packaged SoftwareTechnology Services Part of Topicus.com, Inc., Topicus.com BV provides vertical market software and platforms. The private company is based in Deventer, Netherlands. Robin van Poelje has been the CEO of the Dutch company since 2021. | Technology Services |
Cross-Border Impact Ventures
Cross-Border Impact Ventures Investment ManagersFinance Cross-Border Impact Ventures (Cross-Border Impact Ventures) is a venture capital firm founded in 2019 by Megan Dover. The firm is headquartered in Toronto, Canada. | Finance |
